"De locatie Erasmus MC-Daniel den Hoed bestaat niet meer. De patiëntenzorg is verhuisd naar Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam."

During the past decade, Erasmus MC-Daniel den Hoed Oncologisch Centrum conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erasmus MC-Daniel den Hoed Oncologisch Centrum" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Erasmus MC-Daniel den Hoed Oncologisch Centrum" are "HER2-Positive Primary Breast Cancer" (1 trials), "Melanoma" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Erasmus MC-Daniel den Hoed Oncologisch Centrum" in a lesser frequency.

Most popular intervention types in "Erasmus MC-Daniel den Hoed Oncologisch Centrum" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "LGX818" (1 trials), "MEK162" (1 trials), "T-DM1" (1 trials) and "vemurafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erasmus MC-Daniel den Hoed Oncologisch Centrum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Erasmus MC-Daniel den Hoed Oncologisch Centrum". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Erasmus MC-Daniel den Hoed Oncologisch Centrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erasmus MC-Daniel den Hoed Oncologisch Centrum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".